UBS Group AG's ownership history for MRNA

UBS Group AG currently holds 4.4M shares with a market value of $223.9M. It started holding MRNA on 2024-12-31. At its peak, it held 6.4M shares on 2025-03-31. Its highest holding value was $223.9M on 2026-03-31. At its lowest, it held 3.9M shares on 2025-06-30, with a value of $108.8M on 2025-06-30. In the recent 180 days, UBS Group AG has decreased its shares by 393.6K. In the recent year, UBS Group AG has decreased its shares by 2.0M.

It has also owned 30.9K contracts of calls, with the market value of the underlying securities totaling $157.1M on 2024-12-31. At its peak, it held 49.2K contracts of calls on 2025-12-31 and it owned calls with the market value of the underlying securities totaling $157.1M on 2026-03-31. At its lowest, it held 6.2K contracts of calls on 2024-12-31 and it owned calls with the market value of the underlying securities totaling $25.7M on 2024-12-31. In the recent 180 days, UBS Group AG has decreased its holdings by 6.4K contracts. In the recent year, UBS Group AG has increased its holdings by 1.4K contracts.

It has also owned 8.4K contracts of puts, with the market value of the underlying securities totaling $42.5M on 2024-12-31. At its peak, it held 57.6K contracts of puts on 2025-12-31 and it owned puts with the market value of the underlying securities totaling $169.9M on 2025-12-31. At its lowest, it held 6.1K contracts of puts on 2024-12-31 and it owned puts with the market value of the underlying securities totaling $25.5M on 2024-12-31. In the recent 180 days, UBS Group AG has decreased its holdings by 16.4K contracts. In the recent year, UBS Group AG has increased its holdings by 4.4M contracts.